(Q33336938)

25 July 2017

title

Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy (English)

1 reference

25 July 2017

1 reference

8

Fenaux P

1 reference

25 July 2017

Vantelon JM

1

1 reference

25 July 2017

Munck JN

2

1 reference

25 July 2017

Bourhis JH

3

1 reference

25 July 2017

Pico JL

4

1 reference

25 July 2017

Fadel C

5

1 reference

25 July 2017

Ulusakarya A

6

1 reference

25 July 2017

Carde P

7

1 reference

25 July 2017

Ribrag V

9

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Bone Marrow Transplantation

25 July 2017

published in

1 reference

25 July 2017

volume

27

1 reference

25 July 2017

issue

5

1 reference

25 July 2017

page(s)

531-536

1 reference

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Thrombotic thrombocytopenic purpura: diagnosis, pathogenesis and modern therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Sudden cardiac death from thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Respiratory dysfunction in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Thrombotic thrombocytopenic purpura in pulmonary-renal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

7 January 2021

Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

7 January 2021

Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

7 January 2021

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

7 January 2021

Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702812

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702812

1 reference

Dimensions Publication ID

25 July 2017

1027379541

0 references

1 reference